442 material Form 8-K filings that 386 companies we cover made with the SEC in March 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
AES said its unaudited financial statements for the second and third quarters of 2024 should no longer be relied upon, because impairment expense tied to the sale of its 47.3% stake in AES Brasil was overstated. The company included restated figures in its 2024 Form 10-K and reported a material weakness in internal controls, but said the restatement does not change full-year 2024 net income, EPS, or Adjusted EBITDA.
Impairment expense overstated by about $192 million for the three months ended June 30, 2024, and about $5 million for the three months ended September 30, 2024.
Cause: incomplete data used to estimate the fair value of AES Brasil's net assets after it was classified as held for sale in Q2 2024.
Full-year 2024 net income attributable to AES, EPS, and Adjusted EBITDA are unchanged, per the company.
AES will not file amended 10-Qs for the restated periods; figures are in the 2024 Form 10-K filed March 10, 2025.
Rayonier's subsidiaries agreed on March 9, 2025 to sell their entire 77% interest in the New Zealand joint venture to a vehicle formed by Ents LP, an investment fund managed by The Rohatyn Group, for $710 million, subject to adjustments. Rayonier says the sale is modestly accretive to pro forma CAD per share and lowers pro forma net debt to Adjusted EBITDA to about 0.3x, but the filing's pro forma table also shows Adjusted EBITDA falling from $298.8 million to $245.1 million. Closing is expected in 2025, subject to regulatory approvals.
Purchase price of $710 million for the 77% interest, implying an enterprise value of $922 million for the joint venture
Company expects the sale to be modestly accretive to pro forma CAD per share, with a 1.3% accretion in its pro forma table
Pro forma Adjusted EBITDA is shown at $245.1 million, versus $298.8 million in 2024 before the sale
Closing requires approvals including antitrust in China and South Korea; either party may terminate if not closed by December 9, 2025
Franklin BSP Realty Trust (FBRT) signed a definitive agreement on March 9, 2025, to acquire NewPoint Holdings JV LLC, a commercial real estate finance company. The filing gives $318,750,000 in cash, subject to adjustments, plus 8,385,951 Class A units of FBRT's operating company, and the investor presentation puts the total at $425 million. The company expects the deal to be accretive to GAAP earnings per share in the first half of 2026 but to reduce fully converted book value per share by $0.26 to $0.28 at closing.
Cash consideration of $318,750,000 plus 8,385,951 Class A units of FBRT's operating company, subject to a purchase price adjustment
Expected to close in the third quarter of 2025, subject to closing conditions including regulatory approvals; either party may terminate if not closed by December 9, 2025
Company projects accretion to GAAP EPS in the first half of 2026 and to distributable EPS in the second half of 2026, but a $0.26 to $0.28 reduction in fully converted book value per share at close
NewPoint has a $54.7 billion servicing portfolio as of December 31, 2024 and holds all three agency licenses, which FBRT says will allow it to originate agency loans directly
Quanex reported a fiscal first-quarter net loss of $14.9 million, or $0.32 per diluted share, versus net income of $6.2 million, or $0.19 per share, a year earlier, while net sales rose 67.3% to $400.0 million on the Tyman acquisition. The company reaffirmed its fiscal 2025 guidance of $1.84 billion to $1.86 billion in net sales and $270 million to $280 million in Adjusted EBITDA, and it said it has repaid $65 million of debt since closing the Tyman deal on August 1, 2024.
Net sales were $400.0 million for the three months ended January 31, 2025, up from $239.2 million; Tyman contributed $175.7 million, and excluding Tyman, net sales declined 6.2%.
Net loss was $14.9 million, or $0.32 per diluted share, compared with net income of $6.2 million, or $0.19 per share; restructuring charges were $7.9 million.
Adjusted diluted EPS was $0.19, down from $0.25, and Adjusted EBITDA was $38.5 million, up from $19.3 million.
Fiscal 2025 guidance was reaffirmed: net sales of $1.84 billion to $1.86 billion and Adjusted EBITDA of $270 million to $280 million; total debt was $764.3 million as of January 31, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.